News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 145–180
- Matches
- 54457
- Sources here
- 18
- Companies here
- 32
Search results
Stored financial headlines
Active search
54457 matching headlines
Ticker or company: ARMain company stories
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Thomasville National Bank Purchases Shares of 13,987 Wells Fargo & Company $WFC
Thomasville National Bank has acquired a new position of 13,987 shares in Wells Fargo & Company, valued at approximately $1.16 million, according to its latest SEC filing. Institutional investors now collectively own 75.9% of Wells Fargo's outstanding stock. Analysts maintain a "Moderate Buy" rating …
WFC
main company
Sharemaestro market context
Trend signal started
52 weeks +14.1% · Next-week setup positive 55.9%
Prevail Innovative Wealth Advisors LLC Makes New $7.40 Million Investment in Wells Fargo & Company $WFC
Prevail Innovative Wealth Advisors LLC has made a new $7.40 million investment in Wells Fargo & Company, acquiring 89,518 shares which now represent 1.1% of its portfolio. This investment follows strong quarterly results from Wells Fargo, exceeding earnings and revenue expectations, and the bank …
WFC
main company
Sharemaestro market context
Trend signal started
52 weeks +14.1% · Next-week setup positive 55.9%
Moody Lynn Lieberson & Walker LLC Lowers Stake in Wells Fargo & Company $WFC
Moody Lynn Lieberson & Walker LLC significantly reduced its stake in Wells Fargo & Company (NYSE:WFC) by 72.3% in the second quarter, selling 142,131 shares and retaining 54,365 shares valued at approximately $4.49 million. This reduction comes despite Wells Fargo reporting stronger-than-expected quarterly results …
WFC
main company
Sharemaestro market context
Trend signal started
52 weeks +14.1% · Next-week setup positive 55.9%
Argenx advances as Vyvgart hits key trial endpoints for autoimmune myositis
[Chemistry.] artisteer/iStock via Getty Images * Shares in Argenx SE (ARGX [https://seekingalpha.com/symbol/ARGX]) jumped on Monday after the European biotech reported the latest large, successful trial for its blockbuster drug Vyvgart. * The drug helped patients with autoimmune myositis, a disease in which the immune …
Sharemaestro market context Trend signal active 52 weeks +23.7% · Next-week setup negative 39.6%Cue Biopharma GAAP EPS of -$24.14 misses by $22.23, revenue of $7.88M beats by $5.78M
* Cue Biopharma press release [https://seekingalpha.com/pr/20620099-cue-biopharma-reports-second-quarter-2026-financial-results-and-recent-business-highlights] (CUE [https://seekingalpha.com/symbol/CUE]): Q2 GAAP EPS of -$24.14 misses by $22.23. * Revenue of $7.88M (+167.1% Y/Y) beats by $5.78M. * As of June 30, 2026, the company had $17.4 million in cash and cash equivalents after incurring one-time …
CUE
main company
Sharemaestro market context
Trend signal active
52 weeks +38.0% · Next-week setup negative 44.6%
The Top 5 Analyst Questions From Surgery Partners’s Q2 Earnings Call
The Top 5 Analyst Questions From Surgery Partners's Q2 Earnings Call Surgery Partners' second quarter results were received positively by the market, with management highlighting that revenue and adjusted EBITDA came in ahead of expectations. CEO Eric Evans credited growth in higher-acuity surgical procedures—particularly …
SGRY
main company
Sharemaestro market context
Trend signal active
52 weeks -36.4% · Next-week setup negative 39.0%